Correlation of Serum Clara Cell Secretory Protein 16, Plasma Fibrinogen and Serum Amyloid A with the Severity of Acute Exacerbated COPD and Their Combination in Prognosis Assessment

References

• Hoult G, Gillespie D, Wilkinson TMA, Thomas M, Francis NA. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. BMC Pulm Med. 2022;22(1):194.
   PubMed Web of Science ®Google Scholar
• Ruvuna L, Sood A. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med. 2020;41(3):315–327. doi:10.1016/j.ccm.2020.05.002
   PubMed Web of Science ®Google Scholar
• Tung L-F, Shen S-Y, Shih -H-H, Chen Y-T, C-t Y, S-C H. Effect of high-flow nasal therapy during early pulmonary rehabilitation in patients with severe AECOPD: a randomized controlled study. Respir Res. 2020;21(1):1–11. doi:10.1186/s12931-020-1328-z
   PubMed Web of Science ®Google Scholar
• Oliveira A, Marques A. Understanding symptoms variability in outpatients with AECOPD. Pulmonology. 2018;24(6):357–360. doi:10.1016/j.pulmoe.2018.09.007
   PubMed Web of Science ®Google Scholar
• Yao C, Wang L, Shi F, et al. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure. Int J Med Sci. 2021;18(7):1592. doi:10.7150/ijms.52405
   PubMed Web of Science ®Google Scholar
• Jing Z, Chun C, Ning S, Hong Z, Bei H, Wan-Zhen Y. Systemic inflammatory marker CRP was better predictor of readmission for AECOPD than sputum inflammatory markers. Arch de Bronconeumología. 2016;523:138–144. doi:10.1016/j.arbres.2015.01.011
   PubMed Web of Science ®Google Scholar
• Yin J, Wang S, Qiu Y, et al. Screening for and combining serum intestinal barrier-related biomarkers to predict the disease severity of AECOPD. Ann Palliat Med. 2021;10(2):1548–1559. doi:10.21037/apm-20-1060
   PubMed Web of Science ®Google Scholar
• Dörtkardeş AB, Şahinduran Ş. Determination of serum amyloid A, haptoglobin and hepcidin levels in calves with endemic viral pneumonia. Ankara Üniver Veteriner Fakültesi Dergisi. 2020;67(2):127–131. doi:10.33988/auvfd.523958
   Web of Science ®Google Scholar
• Su W, Ju L, Hua Q, Hu J, Qian W. Values of combined C-reactive protein, procalcitonin and serum amyloid A in differential diagnosis of bacterial and non-bacterial community acquired pneumonia in children. Diagn Microbiol Infect Dis. 2022;105:115865. doi:10.1016/j.diagmicrobio.2022.115865
   PubMed Web of Science ®Google Scholar
• Li H, Xiang X, Ren H, et al. SAA is a biomarker to distinguish the severity and prognosis of Coronavirus Disease 2019 (COVID-19). J Infect. 2020.
   Google Scholar
• Sorić Hosman I, Kos I, Lamot L. Serum amyloid A in inflammatory rheumatic diseases: a compendious review of a renowned biomarker. Front Immunol. 2021;11:631299. doi:10.3389/fimmu.2020.631299
   PubMed Web of Science ®Google Scholar
• Sun W, Cao Z, Ma Y, Wang J, Zhang L, Luo Z. Fibrinogen, a Promising Marker to Evaluate Severity and Prognosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: a Retrospective Observational Study. Int J Chron Obstruct Pulmon Dis. 2022;17:1299. doi:10.2147/COPD.S361929
   PubMed Web of Science ®Google Scholar
• Li M, Wu Y, Han H, Yuan Y. Clinical significance of plasma D-dimer and fibrinogen detection in patients with AECOPD with hypoxemia. J Chine Phys. 2020;1464–1467.
   Google Scholar
• Aydin C, Yıldız BP, Hattatoğlu DG. D-dimer/Fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in patients with COPD exacerbation. Malawi Med J. 2021;33(4):276–280. doi:10.4314/mmj.v33i4.8
   PubMed Web of Science ®Google Scholar
• He Y, Yu J, Zhu D, Gao J. Predictive Value of Serum Markers SFRP1 and CC16 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Evid Based Complement Alternat Med. 2022;2022:1–6. doi:10.1155/2022/6488935
   Web of Science ®Google Scholar
• Kropski JA, Fremont RD, Calfee CS, Ware LB. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest. 2009;135(6):1440–1447. doi:10.1378/chest.08-2465
   PubMed Web of Science ®Google Scholar
• Ni W, Bao J, Yang D, et al. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis. Infect Dis. 2019;51(9):639–650. doi:10.1080/23744235.2019.1644456
   PubMed Web of Science ®Google Scholar
• Bozinovski S, Hutchinson A, Thompson M, et al. Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177(3):269–278. doi:10.1164/rccm.200705-678OC
   PubMed Web of Science ®Google Scholar
• Shah C, Hari-Dass R, Raynes JG. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood. 2006;108(5):1751–1757. doi:10.1182/blood-2005-11-011932
   PubMed Web of Science ®Google Scholar
• Basu S, Mukherjee S, Samanta A. Epidemiological study of bacterial microbiology in AECOPD patients of Kolkata, India. Asian J Pharm Clin Res. 2013;6(1):112–116.
   Google Scholar
• Guo C, Sun X, Diao W, Shen N, He B. Correlation of clinical symptoms and sputum inflammatory markers with air pollutants in stable COPD patients in Beijing area. Int J Chron Obstruct Pulmon Dis. 2020;15:1507. doi:10.2147/COPD.S254129
   PubMed Web of Science ®Google Scholar
• Lin YH, Liao XN, Fan LL, Qu YJ, Cheng DY, Shi YH. Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D. PLoS One. 2017;12(8):e0183300. doi:10.1371/journal.pone.0183300
   PubMed Web of Science ®Google Scholar
• Cavailles A, Melloni B, Motola S, et al. Identification of patient profiles with high risk of hospital re-admissions for acute COPD exacerbations (AECOPD) in France using a machine learning model. Int J Chron Obstruct Pulmon Dis. 2020;15:949. doi:10.2147/COPD.S236787
   PubMed Web of Science ®Google Scholar
• Yuan M, Li P, Wu C. Semiparametric inference of the Youden index and the optimal cut‐off point under density ratio models. Canadian J Statistics. 2021;49(3):965–986. doi:10.1002/cjs.11600
   Web of Science ®Google Scholar